Ross

Ross Garberich, MS, MBA

Vice President, Scientific Services

Ross Garberich serves as the Vice President of Scientific Services for the Minneapolis Heart Institute Foundation. He provides leadership for MHIF’s investigator-initiated research program; partnering with physicians to deliver on MHIF’s mission of innovation by answering research questions and identifying pathways to improve patient care.

In his 15 years at MHIF, Ross has an established track record of designing programs and teams which provide researchers with the tools and services they need to design, conduct, and disseminate research. He has extensive knowledge of leveraging clinical EMRs, data warehouses, and statistics to help execute research and quality improvement studies. With a passion for collaboration, Ross has co-authored over 125 peer-reviewed publications spanning all sub-specialties within cardiology.

Ross earned his bachelor's degree from the University of Minnesota Duluth where he also received a Master’s degree in Applied and Computational Mathematics and his MBA. He lives in Chaska, Minn. with his wife and two children.

Back to Leadership Team

Image
Twitter Icon
Image
LinkedIn Icon
Ross
Give the Gift of Hope
4 photos of families smiling

The Minneapolis Heart Institute Foundation® (MHIF) strives to create a world without heart and vascular disease. To achieve this bold vision, we are dedicated to improving the cardiovascular health of individuals and communities through innovative research and education.

Thanks to the generosity of donors like you, we can continue this life-saving work. Please make a gift to support the area of greatest need.

Research Milestone: FDA approves device used as alternative to open-heart

blue background
Triclip team

We are honored to celebrate the culmination of years of research that has resulted in new technologies for patients! In the few last weeks, we announced a similar research milestone with the FDA approval of the TriClip system for tricuspid regurgitation. We celebrated this important milestone with local media KSTP-TV, who spotlighted the importance of this new technology. We were proud to be a leading clinical site led by Global PI Dr. Paul Sorajja and the MHIF research team who contributed significant data to the pivotal trial.